These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16926637)

  • 1. Severe enteropathy associated with raltitrexed and oxaliplatin chemotherapy: report of two patients experiencing this rare, potentially lethal gastrointestinal adverse event.
    Wenzel C; Urbauer E; Schwarz C; Funk G; Oehler L; Kornek GV; Scheithauer W
    Anticancer Drugs; 2006 Aug; 17(7):865-8. PubMed ID: 16926637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective study.
    Khouri C; Guiu B; Cercueil JP; Chauffert B; Ladoire S; Ghiringhelli F
    Anticancer Drugs; 2010 Jul; 21(6):656-61. PubMed ID: 20216061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of infusional biomodulated 5-fluorouracil in metastatic colorectal cancer after raltitrexed failure.
    Decoster L; Neyns B; Akouaouach H; Fontaine C; Schallier D; De Grève JL
    Anticancer Res; 2004; 24(3b):2037-40. PubMed ID: 15274397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raltitrexed in colorectal cancer.
    Drug Ther Bull; 1996 Oct; 34(10):78-80. PubMed ID: 8936802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of Raltitrexed ('Tomudex') in elderly patients with colorectal cancer.
    Romiti A; Tonini G; Santini D; Di Seri M; Masciangelo R; Mezi S; Verì A; Santuari L; Vincenzi B; Brescia A; Marchei P; Frati L; Tomao S
    Anticancer Res; 2002; 22(5):3071-6. PubMed ID: 12530045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Raltitrexed and oxaliplatin in colorectal cancer: in vitro and in vivo study of a synergistic cytostatic combination].
    Schüll B; Scheithauer W
    Acta Med Austriaca; 2002; 29(4):124-31. PubMed ID: 12424937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1).
    Popov I; Carrato A; Sobrero A; Vincent M; Kerr D; Labianca R; Raffaele Bianco A; El-Serafi M; Bedenne L; Paillot B; Mini E; Sanches E; Welch J; Collette L; Praet M; Wils J
    Eur J Cancer; 2008 Oct; 44(15):2204-11. PubMed ID: 18707870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis.
    Kuebler JP; Colangelo L; O'Connell MJ; Smith RE; Yothers G; Begovic M; Robinson B; Seay TE; Wolmark N
    Cancer; 2007 Nov; 110(9):1945-50. PubMed ID: 17853393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy with raltitrexed in patients with colorectal cancer intolerant of 5-fluorouracil: British Columbia Cancer Agency experience.
    Wilson KS; Fitzgerald CA; Barnett JB; Gill S; Khoo KE
    Cancer Invest; 2007 Dec; 25(8):711-4. PubMed ID: 18058467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raltitrexed plus oxaliplatin as first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trial.
    Neri B; Doni L; Fulignati C; Perfetto F; Turrini M; Andreoli F; Pantalone D; Pernice LM; Taruffi F; Martini V; Poma A; Valeri A; Bacci G; Sancez L; Moretti R
    Anticancer Drugs; 2002 Aug; 13(7):719-24. PubMed ID: 12187328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
    Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
    Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
    Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutropenic enterocolitis in a patient with colorectal carcinoma: unusual course after treatment with 5-fluorouracil and leucovorin--a case report.
    Kronawitter U; Kemeny NE; Blumgart L
    Cancer; 1997 Aug; 80(4):656-60. PubMed ID: 9264347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
    In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A late phase II study of raltitrexed (ZD 1694) in chemotherapy-naive patients with advanced colorectal cancer].
    Nishisho I; Kikkawa N; Ebata T; Osanai H; Ujiie S; Mitachi Y; Tsutsui M; Sawai K; Nishiguchi Y; Yasutake K; Wakasugi H; Wakui A
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):81-91. PubMed ID: 10660737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-operative radiochemotherapy with raltitrexed for resectable locally-advanced rectal cancer: a phase II study.
    Leonardi MC; Zampino MG; Luca F; Jereczek-Fossa BA; Petazzi E; Tatani B; Lazzari R; Biffi R; Lorizzo K; Magni E; Scanniffio D; Orsi F; Bonomo G; Petralia G; Trovato C; Crosta C; Andreoni B; Orecchia R
    Anticancer Res; 2006; 26(3B):2419-23. PubMed ID: 16821626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.
    Dahabreh I; Tsoutsos G; Tseligas D; Janinis D
    BMC Clin Pharmacol; 2006 Sep; 6():5. PubMed ID: 16968538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.